Northside Hospital Cancer Institute Immunotherapy Program now offers access to another chimeric antigen receptor (CAR) T-cell immunotherapy for treatment of adult acute lymphoid leukemia and certain types of non-Hodgkin’s lymphoma.
Main Content
Current Issue
